Dr. Richard Manning is a Managing Director at Intensity, LLC. He provides data-driven insights to help clients in law firms, businesses, and government agencies solve complex economic problems including valuation of early-stage companies and strategic investments; evaluating mergers and acquisitions; and other financial analyses. His primary focus is matters involving biopharmaceuticals, health care, life sciences, and animal health.
His areas of expertise include:
- Economic Valuation and Damages
- Breach of Contract, Fraud, and other Commercial Litigation
- Intellectual Property
- Securities Litigation
- Tax, Antitrust and Competition
- Public Policy
Dr. Manning has testified in U.S. District Court, U.S. Bankruptcy Court, the Delaware Court of Chancery, and the International Chamber of Commerce; served as consulting expert and prepared reports and commentary on a wide range of issues in the biopharmaceutical (both innovative and follow-on sectors) and healthcare industries. His career includes 14 years as an executive at multinational pharmaceutical companies where he led economic analysis and strategy development to shape practices related to emerging business concerns.
Examples of Dr. Manning’s work include:
| Economic analysis and strategy relative to challenges affecting pricing, reimbursement, marketing, manufacturing, R&D investments, and intellectual property protection, including commercial success, Paragraph IV and reverse settlements.
| Economic valuation of early-stage companies and strategic investments; evaluating merger and acquisitions; and other financial analyses.
| Analyzing healthcare benefit design; healthcare system reforms; FDA regulatory reform, including biosimilars review processes and product safety.
Prior to joining Intensity, Dr. Manning was a Partner at Bates White, an economic consulting firm offering analysis and expert testimony services to law firms, Fortune 500 companies, and government agencies. Previously, Dr. Manning was Executive Director at Merck & Co., Inc., and he was Senior Director at Pfizer, Inc. Dr. Manning was also a Director in the Advisory Strategy Group at PricewaterhouseCoopers.
Dr. Manning was an economics professor at Brigham Young University and a visiting professor in the Graduate School of Business at the University of Chicago. As an academic, his teaching and research focused on price theory, the economic analysis of law, industrial organization, and the economics of government regulation.
Dr. Manning received his Ph.D. in Economics from the University of Chicago. He earned his B.A. in Economics from Brigham Young University.